Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grainger

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Pediatric Blood & Cancer|August 1, 2012
Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP toolsRobert J Klaassen, Victor Blanchette, Tricia A Burke, et al.
Anaesthesia|July 21, 2010
Safety in magnetic resonance units: an update, P A Farling, P A Flynn, et al.
Translational Psychiatry|April 1, 2015
Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmissionL Scoriels, R M Salek, E Goodby, et al.
Journal of Public Health, and Sanitary Review|November 1, 2018
On the Construction and Sanitary Arrangements of Barracks, and HospitalsNeil Arnott, B G Babington, James Bird, et al.
British Journal of Haematology|November 24, 2016
A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonistsJecko Thachil, Catherine Bagot, Charlotte Bradbury, et al.
Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.
Pediatric Blood & Cancer|December 2, 2016
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemiaB Vormoor, G J Veal, M J Griffin, et al.
The Lancet. Haematology|December 22, 2015
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled studyJames B Bussel, Purificación Garcia de Miguel, Jenny M Despotovic, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Pediatric Blood & Cancer|August 1, 2012
Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP toolsRobert J Klaassen, Victor Blanchette, Tricia A Burke, et al.
Anaesthesia|July 21, 2010
Safety in magnetic resonance units: an update, P A Farling, P A Flynn, et al.
Translational Psychiatry|April 1, 2015
Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmissionL Scoriels, R M Salek, E Goodby, et al.
Journal of Public Health, and Sanitary Review|November 1, 2018
On the Construction and Sanitary Arrangements of Barracks, and HospitalsNeil Arnott, B G Babington, James Bird, et al.
British Journal of Haematology|November 24, 2016
A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonistsJecko Thachil, Catherine Bagot, Charlotte Bradbury, et al.
Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.
Pediatric Blood & Cancer|December 2, 2016
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemiaB Vormoor, G J Veal, M J Griffin, et al.
The Lancet. Haematology|December 22, 2015
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled studyJames B Bussel, Purificación Garcia de Miguel, Jenny M Despotovic, et al.
Pageof 9